Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Goshima

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Hepato-Gastroenterology|July 17, 2007
Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination modelsS Shimoyama, F Goshima, O Teshigahara, et al.
The Journal of General Virology|September 20, 2000
The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for virus envelopmentC Shiba, T Daikoku, F Goshima, et al.
Archives of Virology|February 7, 2001
Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cellsF Goshima, D Watanabe, H Takakuwa, et al.
Archives of Virology|August 4, 1998
Characterization of the UL4 gene product of herpes simplex virus type 2H Yamada, Y M Jiang, S Oshima, et al.
The Journal of General Virology|November 20, 1998
Characterization of the herpes simplex virus type 2 (HSV-2) US2 gene product and a US2-deficient HSV-2 mutantY M Jiang, H Yamada, F Goshima, et al.
The Journal of General Virology|January 25, 2000
Mitochondrial distribution and function in herpes simplex virus-infected cellsT Murata, F Goshima, T Daikoku, et al.
Virus Genes|July 14, 2001
Identification and characterization of the UL24 gene product of herpes simplex virus type 2Z Hong-Yan, T Murata, F Goshima, et al.
Virology|October 6, 2000
A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virusH Tsunobuchi, H Nishimura, F Goshima, et al.
Virology|August 18, 1997
Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2T Daikoku, S Shibata, F Goshima, et al.
Cancer Gene Therapy|August 19, 2007
Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virusS-I Kohno, C Luo, A Nawa, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Hepato-Gastroenterology|July 17, 2007
Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination modelsS Shimoyama, F Goshima, O Teshigahara, et al.
The Journal of General Virology|September 20, 2000
The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for virus envelopmentC Shiba, T Daikoku, F Goshima, et al.
Archives of Virology|February 7, 2001
Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cellsF Goshima, D Watanabe, H Takakuwa, et al.
Archives of Virology|August 4, 1998
Characterization of the UL4 gene product of herpes simplex virus type 2H Yamada, Y M Jiang, S Oshima, et al.
The Journal of General Virology|November 20, 1998
Characterization of the herpes simplex virus type 2 (HSV-2) US2 gene product and a US2-deficient HSV-2 mutantY M Jiang, H Yamada, F Goshima, et al.
The Journal of General Virology|January 25, 2000
Mitochondrial distribution and function in herpes simplex virus-infected cellsT Murata, F Goshima, T Daikoku, et al.
Virus Genes|July 14, 2001
Identification and characterization of the UL24 gene product of herpes simplex virus type 2Z Hong-Yan, T Murata, F Goshima, et al.
Virology|October 6, 2000
A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virusH Tsunobuchi, H Nishimura, F Goshima, et al.
Virology|August 18, 1997
Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2T Daikoku, S Shibata, F Goshima, et al.
Cancer Gene Therapy|August 19, 2007
Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virusS-I Kohno, C Luo, A Nawa, et al.
Pageof 5